Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SHAH MAHENDRA
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-05-04
Sale
2021-05-05
5:03 pm
Verona Pharma plc VRNA SHAH MAHENDRA
Director
10,680 $0.8397 $8,968 73,080
(Direct)
View
2021-02-09
Sale
2021-02-09
3:33 pm
Bolt Biotherapeutics Inc. BOLT SHAH MAHENDRA
Director
62 $20 $1,240 1,448,286
(Indirect)
View
2021-02-01
Sale
2021-02-03
7:10 pm
Verona Pharma plc VRNA SHAH MAHENDRA
Director
10,800 $0.9938 $10,733 83,760
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-16
Option Award
2022-06-17
5:05 pm
N/A
2032-06-15
IMPEL PHARMACEUTICALS INC IMPL SHAH MAHENDRA
Director
12,789 $0 12,789
(Direct)
View
2022-06-10
Option Award
2022-06-10
6:28 pm
N/A
2032-06-09
Bolt Biotherapeutics Inc. BOLT SHAH MAHENDRA
Director
25,000 $0 25,000
(Direct)
View
2022-04-28
Option Award
2022-04-29
4:42 pm
N/A
2032-04-27
Verona Pharma plc VRNA SHAH MAHENDRA
Director
200,000 $0 200,000
(Direct)
View
2022-03-24
Option Award
2022-03-28
3:18 pm
N/A
2032-03-23
Bolt Biotherapeutics Inc. BOLT SHAH MAHENDRA
Director
25,000 $0 25,000
(Direct)
View
2021-08-09
Option Award
2021-08-10
4:45 pm
N/A
2031-08-08
Verona Pharma plc VRNA SHAH MAHENDRA
Director
64,000 $0 64,000
(Direct)
View
2021-07-11
Option Award
2021-07-13
5:10 pm
N/A
2031-07-10
IMPEL NEUROPHARMA INC IMPL SHAH MAHENDRA
Director
11,500 $0 11,500
(Direct)
View
2021-04-22
Ownership
2021-04-22
7:14 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL SHAH MAHENDRA
Director
0 $0 0
(Direct)
View
2021-02-09
Exercise
2021-02-09
3:33 pm
N/A
2028-07-26
Bolt Biotherapeutics Inc. BOLT SHAH MAHENDRA
Director
17,711 $0 1,448,286
(Indirect)
View
2021-02-09
Conversion
2021-02-09
3:33 pm
N/A
N/A
Bolt Biotherapeutics Inc. BOLT SHAH MAHENDRA
Director
1,416,352 $0 1,448,286
(Indirect)
View
2021-02-09
Exercise
2021-02-09
3:33 pm
N/A
N/A
Bolt Biotherapeutics Inc. BOLT SHAH MAHENDRA
Director
17,711 $0.07 1,448,286
(Indirect)
View
2021-02-04
Ownership
2021-02-04
6:20 pm
N/A
N/A
Bolt Biotherapeutics Inc. BOLT SHAH MAHENDRA
Director
0 $0 1,448,348
(Indirect)
View
2021-01-01
Ownership
2021-01-04
8:23 pm
N/A
N/A
Verona Pharma plc VRNA SHAH MAHENDRA
Director
0 $0 94,560
(Direct)
View
2018-06-11
Option Award
2018-06-18
6:14 pm
N/A
2028-06-11
SOLENO THERAPEUTICS INC SLNO SHAH MAHENDRA
Director
15,931 $0 15,931
(Direct)
View
2018-04-02(A)
Option Award
2018-05-16
4:05 pm
N/A
N/A
Homology Medicines Inc. FIXX SHAH MAHENDRA
Director
250,000 $16 909,742
(Indirect)
View
2018-04-02
Conversion
2018-04-04
4:45 pm
N/A
N/A
Homology Medicines Inc. FIXX SHAH MAHENDRA
Director
659,742 $0 1,159,742
(Indirect)
View
2018-04-02
Option Award
2018-04-04
4:45 pm
N/A
N/A
Homology Medicines Inc. FIXX SHAH MAHENDRA
Director
500,000 $16 1,159,742
(Indirect)
View
2018-03-27
Option Award
2018-03-29
6:30 pm
N/A
2028-03-27
Homology Medicines Inc. FIXX SHAH MAHENDRA
Director
31,160 $0 31,160
(Direct)
View
2018-03-27
Ownership
2018-03-27
5:59 pm
N/A
N/A
Homology Medicines Inc. FIXX SHAH MAHENDRA
Director
0 $0 659,742
(Indirect)
View
2018-02-05
Option Award
2018-02-07
8:06 pm
N/A
N/A
SOLENO THERAPEUTICS INC SLNO SHAH MAHENDRA
Director
3,466 $1.7263 27,153
(Direct)
View
(A) Indicate amendment filing.